What are the delavirdine (Rescriptor) dosing guidelines for antiretroviral therapy of HIV infection?

Updated: Apr 18, 2019
  • Author: R Chris Rathbun, PharmD, BCPS (AQ-ID), AAHIVP; Chief Editor: John Bartlett, MD  more...
  • Print
Answer

Answer

Delavirdine (Rescriptor) (Note: Discontinued in the U.S. with estimated availability for 100-mg tablets until October 2018 and for 200-mg tablets until February 2020):

  • Dosage forms: 100-mg, 200-mg tablets
  • Adult dose: 400 mg PO tid
  • Adverse events: Rash, headache

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!